LGND

NASDAQStock

Ligand Pharmaceuticals Incorporated

$209.96-11.28 (-5.10%)

52-Week Range

$96.67

$221.24

Key Stats

Market Cap

4.2B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

Volume

340.1K

Avg Volume

228.2K

Performance

+13.72%

+9.64%

+27.77%

YTD

+11.24%

+100.23%

+199.38%

+29.55%

Price Chart

ETF Exposure

LGND is held by 121 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.01%	3,061	$651K	$12.10B	0.03%
VTI	Vanguard Total Stock Market ETF	0.01%	589,619	$113.3M	$2.10T	0.03%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	13	$3K	$26.4M	0.50%
LITL	Simplify Piper Sandler US Small-Cap PLUS Income ETF	0.00%	1	$212	$5.9M	0.91%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.00%	322	$68K	$1.90B	0.26%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	296	$57K	$1.46B	0.24%
VLU	State Street SPDR S&P 1500 Value Tilt ETF	0.00%	110	$23K	$618.9M	0.12%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	10	$2K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	7	$1K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	5	$1K	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	2	$490	$9.5M	0.12%
VT	Vanguard Total World Stock ETF	0.00%	13,944	$2.7M	$80.60B	0.06%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	442	$94K	$2.84B	0.19%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	11	$2K	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	13	$3K	$59.0M	0.11%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	44	$9K	$733.2M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	133	$28K	$1.69B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	385	$82K	$3.28B	0.20%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	5	$1K	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	9	$2K	$81.7M	0.11%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	2	$346	$61.4M	0.09%

PreviousPage 3 of 3

About LGND ETF Exposure

Ligand Pharmaceuticals Incorporated (LGND) is held by 121 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.2B, LGND is a widely held institutional stock. The stock currently trades at $209.96. Investors can gain exposure to LGND through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LGND, sorted by portfolio weight.